TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 126 filers reported holding TREACE MED CONCEPTS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,719,600 | -48.7% | 360,000 | 0.0% | 0.35% | -51.0% |
| Q2 2023 | $9,208,800 | -32.3% | 360,000 | -33.3% | 0.71% | -20.6% |
| Q1 2023 | $13,602,600 | -7.2% | 540,000 | -15.3% | 0.90% | -2.0% |
| Q4 2022 | $14,651,918 | +12.8% | 637,317 | +8.3% | 0.92% | +47.8% |
| Q3 2022 | $12,984,000 | +53.9% | 588,308 | 0.0% | 0.62% | +49.2% |
| Q2 2022 | $8,436,000 | -10.9% | 588,308 | +17.6% | 0.42% | -16.8% |
| Q1 2022 | $9,463,000 | +1.4% | 500,421 | 0.0% | 0.50% | +12.9% |
| Q4 2021 | $9,328,000 | +22.2% | 500,421 | +76.3% | 0.44% | +11.9% |
| Q3 2021 | $7,633,000 | -24.4% | 283,769 | -12.1% | 0.40% | -11.8% |
| Q2 2021 | $10,097,000 | – | 323,000 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 1,907,823 | $25,011,560 | 2.31% |
| FORMULA GROWTH LTD | 222,269 | $2,913,947 | 0.99% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,193,939 | $15,652,540 | 0.94% |
| EMERALD ADVISERS, LLC | 1,473,281 | $19,314,713 | 0.94% |
| Perceptive Advisors | 1,834,060 | $24,044,527 | 0.80% |
| NEXT CENTURY GROWTH INVESTORS LLC | 512,738 | $6,721,995 | 0.73% |
| OBERWEIS ASSET MANAGEMENT INC/ | 355,600 | $4,661,916 | 0.50% |
| Novo Holdings A/S | 360,000 | $4,719,600 | 0.35% |
| TimesSquare Capital Management, LLC | 1,433,429 | $18,792 | 0.29% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 677,733 | $8,885,080 | 0.18% |